A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib

Bibliographic Details
Main Authors:	Mary Clark, MD, Paul Imbriano, DO, Michael Harwood, MD, Klaus Busam, MD, Leslie Robinson-Bostom, MD
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	JAAD Case Reports
Subjects:	BRAF inhibitor hairy cell leukemia melanoma vemurafenib
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622001333

Internet